|
Purpose of the guideline：
|
PSMA PET has been widely used in the diagnosis, staging, and detection of recurrent sites of prostate cancer, becoming an important imaging tool in the management of prostate cancer treatment. This consensus aims to provide the latest evidence and standards for PSMA PET imaging in prostate cancer, guiding its application in clinical practice and research. The main contents include indications for examination, job responsibilities of medical staff, standard operating procedures for examination, reporting, quality control, and radiation safety issues during imaging. Through the formulation and implementation of this consensus, guidance and support are provided to clinicians and technicians, promoting the application and development of PSMA PET in the management of prostate cancer treatment. |
